The MSB share price down 14%. The Mesoblast [ASX:MSB] posted a FY21 net loss of $98.8 million as the FDA asks for further trials of MSB’s emergency COVID treatment...
ASX:MSB Chart by TradingView
Mesoblast Ltd (ASX:MSB) Company Information
Mesoblast Ltd (ASX:MSB) Financial Information
ASX:MSB Fundamental Data / Rates by TradingView